why choose us

Clinical Trials Search

Showing 11,270 of 132,366 result(s)
Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed;Refractory Multiple Myeloma

Status: NOT_YET_RECRUITING

Condition: Refractory Multiple Myeloma

Interventions:

Participants will receive Iberdomide (Iber) therapy orally (PO) in capsules as follows:

  • Combination therapy: Cycles 1 to 8: 1 mg per day

    Date: 2023-05-31

OM202JP Clinical Study of KNP2002

Status: Completed

Condition: Common Wart

Interventions: Dairy topical administration for 12 weeks

Date: 2023-05-31

Addressing Disparities in Neuromodulation for Rehabilitation: A Mixed Methods Approach to Optimize Access for Underrepresented Racial Minorities

Status: NOT_YET_RECRUITING

Condition: Neuropathic Pain

Interventions: One third of the participants will see the taVNS video once in person.
The video will be 2-3 minutes in length and contain information on the pro

Date: 2023-05-31

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Status: NOT_YET_RECRUITING

Condition: Breast Cancer

Interventions: The program will includes 8 non-speeded exercises that include spin-offs of such games as breaking hex, lineup four, battleship, gems swap, double klo

Date: 2023-05-31

SHR1701 Alone or in Combination With SHR2554 in Relapsed or Refractory Classical Hodgkin Lymphoma

Status: Completed

Condition: Relapsed or Refractory Hodgkin Lymphoma

Interventions: SHR2554: 350mg;day, PO, twice a day.
SHR1701: recommended dose from phase I trial, IV, over 30 minutes.

Date: 2023-05-31

Treatment of HCV-Infected Recent Injection Drug Users in U.S. Liver Clinics

Status: ACTIVE_NOT_RECRUITING

Condition: Chronic Hepatitis C

Interventions: Directly active antiviral therapy (velpatasvir 100 mg+sofobuvir 400 mg) once daily

Date: 2023-05-31

THE EFFECT OF RADIOFREQUENCY ON POSTMENOPAUSAL ADIPOSE TISSUE

Status: NOT_YET_RECRUITING

Condition: Show Positive Effect of Radiofrequancy on Postmenopausal Adipose Tissue

Interventions:

  • Power of device: 150 W
  • Duration of the session: 40 minutes
  • Frequency: 2 sessions per week for 8 week.
  • Heating temperat

    Date: 2023-05-31

Functional Outcome After Minimally Invasive Pyeloplasty for Adult Patients With UPJO

Status: Completed

Condition: Ureteropelvic Junction Obstruction

Interventions: repair of the uPJO

Date: 2023-05-31

Self-Adjusted Nitrous Oxide: A Feasibility Study in the Setting of Vasectomy

Status: Completed

Condition: Procedural Pain

Interventions: Nitrous oxide administered at concentrations of minimal sedation (0-50%).
Participants will be able to adjust the level of gas throughout the vas

Date: 2023-05-31

HPV-T in HPV-16 Positive Recurrent or Metastatic Solid Tumors

Status: Completed

Condition: Solid Tumor

Interventions: Participant will receive HPV-T iv on day 0. One time of cell infusion constitute a cycle, each participant receives up to four cycles of treatment

Date: 2023-05-31